Issuer Flash: China Petroleum & Chemical Corporation / Sinopec Corp.

Report date: 2026-08-28 Event date: 2026-08-24 Event title: H1 2026 Interim Results

1. Flash Conclusion

Sinopec Corp.'s H1 2026 results are supportive of the credit profile set out in the May 2026 issuer summary. IFRS operating profit rose 11.3% year on year to RMB37.2bn and profit attributable to shareholders rose 11.9% to RMB26.6bn, while operating cash flow recovered to RMB62.5bn after the Q1 outflow. Upstream earnings and a sharp increase in refining profitability more than offset weaker fuel-marketing volumes and a still-loss-making chemicals business. The result therefore reduces the immediate concern that the Q1 profit rebound would fail to convert into cash generation, but does not establish a through-cycle earnings upgrade.

The quality of the improvement is mixed. Refining benefited from higher product margins and inventory gains as crude and refined-product prices rose, whereas throughput and refined-product sales declined. Chemicals reduced its operating loss materially but remained loss-making in a weak-demand market, and Marketing and Distribution profit fell as high oil prices and alternative-energy substitution reduced fuel volumes. For bondholders, large cash balances, operating cash flow and disclosed PRC bank facilities continue to support liquidity; however, this remains a capital-intensive, low-margin integrated operator exposed to commodity-price movements, domestic fuel-demand transition and refinancing needs. Sinopec Group control and central-SOE background remain supportive context, not an explicit guarantee of Sinopec Corp. debt.

2. H1 Results: Higher Earnings, Uneven Operating Drivers

The unaudited IFRS interim report recorded revenue of RMB1,436.6bn, up 2.0% year on year, and operating profit of RMB37.2bn, up 11.3%. Profit attributable to shareholders was RMB26.6bn, up 11.9%. The report attributes the improvement to higher oil prices, stepped-up upstream development, higher-value refining products and inventory gains. Net finance costs decreased 21.1% to RMB6.7bn, while investment income and the share of associates' and joint ventures' profit increased 16.4% to RMB7.1bn. These factors are constructive, but the result is not solely a volume-led improvement in the underlying downstream franchise.

Exploration and Production operating profit increased 21.5% to RMB28.7bn. Oil and gas output was broadly stable at 263.47 million boe, including natural-gas output up 0.7%. This offsets weak downstream conditions, but the earnings gain also reflected higher oil prices and associated taxes.

Refining was the principal positive swing factor: segment operating profit increased to RMB17.0bn from RMB3.5bn despite refinery throughput declining 5.6% to 113.31 million tonnes. Refining margin rose 44.1% to RMB453 per tonne as kerosene, naphtha and refining by-product margins improved, and the company reported inventory gains from higher crude and refined-product prices. This demonstrates the value of the integrated system and procurement/product-mix flexibility, but also means that repeating H1 profitability depends on margins, product pricing and inventory conditions that could reverse.

Downstream demand remains cautious. Total refined-product sales fell 9.9% to 100.99 million tonnes, domestic sales fell 9.2% to 79.00 million tonnes and Marketing and Distribution operating profit fell 28.6% to RMB5.7bn. Management cites high prices and accelerated new-energy substitution; automotive LNG, EV charging, battery swapping and hydrogen do not yet replace conventional fuel earnings.

Chemicals remains the principal operating constraint, though its direction improved. Segment revenue declined 1.6% to RMB238.1bn, ethylene production fell 15.5% to 6.394 million tonnes and the segment recorded an RMB0.2bn operating loss, compared with an RMB4.2bn loss in H1 2025. Cost, feedstock, operating-load and export measures reduced the loss, but management still describes domestic chemical demand as weak and plans further cost reduction and product-mix optimisation. The smaller loss is a positive development; it is not evidence that overcapacity and weak demand have been resolved.

3. Cash Flow, Funding and Capital Allocation

H1 net cash generated from operating activities was RMB62.5bn, 2.4% above the prior year and a meaningful improvement from the negative Q1 operating cash flow highlighted in the prior report. Capital expenditure was RMB48.7bn, including RMB28.4bn in E&P and RMB9.8bn in chemicals. Management directly disclosed H2 capex guidance of RMB82.9bn-RMB99.9bn, rather than this being an analyst-derived residual from full-year guidance. Full-year cash conversion should therefore be judged after this spending programme, dividends, interest and debt movements rather than from H1 operating cash flow alone.

At 30 June 2026, cash and cash equivalents plus time deposits were RMB185.8bn, compared with RMB150.9bn at year-end 2025. Short-term debt was RMB110.5bn and long-term debt was RMB246.8bn, up from RMB108.3bn and RMB215.1bn, respectively, at year-end. The report also discloses RMB707.8bn of unsecured standby borrowing facilities from PRC financial institutions, of which RMB75.1bn was outstanding. This combination supports the company's stated ability to meet obligations, but current funding needs extend beyond short-term debt to group loans, lease liabilities, working-capital liabilities and the planned investment programme. The liability-to-asset ratio was 54.3%, broadly stable from 54.1% at year-end, while the reported debt-to-capital ratio rose to 24.0% from 22.1%.

The interim report's group-level contractual-maturity table places RMB544.4bn of undiscounted financial liabilities within one year or on demand. This total includes RMB111.4bn of short-term debt, RMB43.7bn of long-term debt maturities, RMB15.9bn of group-company and fellow-subsidiary loans, RMB19.6bn of lease liabilities, as well as trade/payable and other working-capital obligations. It is broader than financial debt alone and therefore should not be compared mechanically with cash. Nonetheless, cash, H1 operating cash flow and the disclosed standby facilities provide material liquidity resources against the near-term profile. These are consolidated group disclosures and do not establish issue-specific maturity, guarantee, ranking or recovery terms.

The board approved an interim dividend of RMB0.105 per share, totalling RMB12.7bn, versus RMB0.088 per share and RMB10.7bn for H1 2025. The larger payout is manageable against H1 operating cash flow and liquidity, but reinforces the need to monitor full-year free-cash-flow headroom when capex and commodity prices are volatile.

4. What To Watch Next

The next update should test whether H2 refining margins and inventory effects hold as the company plans to process 113 million tonnes of crude, and whether the sharper H1 decline in refined-product volumes persists. It should also test whether chemicals can become profitable rather than merely reduce losses, particularly as management continues to cite weak demand. Bond investors should follow operating cash flow after the H2 capex programme, the size and use of standby facilities, debt maturities, any rating action and the balance between shareholder distributions and deleveraging.

The confirmed H1 result is constructive for Sinopec Corp.'s own consolidated credit profile, but it does not resolve the outstanding structural questions in the issuer summary: individual debt documentation, latest issuer-specific international rating rationales, foreign-currency funding and current market relative value. Those matters require their own primary documents before an issue-level investment conclusion.

5. Sources

• China Petroleum & Chemical Corporation, Interim Results Announcement for the Six Months Ended 30 June 2026, released 2026-08-23, HKEX PDF. Used for unaudited IFRS financials, segment performance, operations, liquidity, capex, dividend and management outlook.
• Shanghai Stock Exchange, China Petroleum & Chemical Corporation announcement page, accessed 2026-08-28. Used to confirm the 2026 Interim Report filing dated 2026-08-24.
• China Petroleum & Chemical Corporation, 2025 Annual Report, published 2026-03-22, and 2026 First Quarterly Report, released 2026-04-28. Used only for comparison with the existing issuer view.